Document Detail


Ketorolac in thyroid surgery: quantifying the risk of hematoma.
MedLine Citation:
PMID:  21518639     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Hematoma is a potentially life-threatening complication of thyroid surgery. Ketorolac is a nonsteroidal anti-inflammatory drug with known antiplatelet activity that is used for analgesia. The goal of this study was to determine the risk of hematoma in patients who received ketorolac in thyroid surgery.
DESIGN: Retrospective cohort study.
SETTING: London Health Sciences Centre.
METHODS: A retrospective cohort study was conducted of patients who underwent thyroid surgery between 2002 and 2007. Data were analyzed using the Fisher exact test.
MAIN OUTCOME MEASURES: Incidence of postoperative hematoma and perioperative ketorolac administration.
RESULTS: Thirteen hematomas occurred in 799 patients. Of the 799, 183 patients received ketorolac (22.9%) and 616 did not. Five in the ketorolac group (2.73%) and eight in the nonketorolac group (1.30%) developed hematomas. The calculated relative risk was 2.10 (95% CI 0.70-6.35).
CONCLUSIONS: Although there was an increased incidence of hematomas in the group receiving ketorolac, the difference was not statistically significant. The lack of significance may be due to the low number of hematomas.
Authors:
Christopher J Chin; Jason H Franklin; Benjamin Turner; Leigh Sowerby; Kevin Fung; John H Yoo
Related Documents :
21443579 - Transcatheter closure of secundum atrial septal defect in infants less than 12 months o...
22555309 - Outcomes of minimally invasive valve surgery in patients with chronic obstructive pulmo...
21437759 - Role of intravitreal bevacizumab in adult onset coats' disease.
21136019 - Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty...
21453659 - Effect of fibula free flap harvest on the gait of head and neck cancer patients: prelim...
2262649 - A double-blind comparison of intranasal budesonide with placebo for nasal polyposis.
25485879 - The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder ...
17666169 - Outcome after distal metatarsal osteotomy for hallux valgus: a prospective randomized c...
7949709 - Young investigator award. in vivo treatment of infected prosthetic graft material with ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale     Volume:  40     ISSN:  1916-0216     ISO Abbreviation:  J Otolaryngol Head Neck Surg     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-04-26     Completed Date:  2011-08-11     Revised Date:  2013-04-10    
Medline Journal Info:
Nlm Unique ID:  101479544     Medline TA:  J Otolaryngol Head Neck Surg     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  196-9     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, London Health Sciences Centre, University of Western Ontario, London, ON.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Female
Hematoma / chemically induced*
Humans
Ketorolac / adverse effects*
Male
Middle Aged
Thyroid Gland / surgery*
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 66635-83-4/Ketorolac

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Results in the management of malignant submandibular tumours and guidelines for elective neck treatm...
Next Document:  Comparison of endoscopic laser resection versus radiation therapy for the treatment of early glottic...